Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma

Br J Haematol. 2014 Feb;164(3):454-6. doi: 10.1111/bjh.12624. Epub 2013 Oct 25.

Authors

David Azoulay¹, David Lavie, Netanel Horowitz, Celia Suriu, Moshe E Gatt, Luiza Akria, Riki Perlman, Andrei Braester, Dina Ben-Yehuda

Affiliation

¹ Haematology Institute, Western Galilee Hospital, Naharia, Israel; Bar Ilan Faculty of Medicine, Safed, Israel. david.azoulay@naharia.health.gov.il.

PMID: 24164472
DOI: 10.1111/bjh.12624

No abstract available

Keywords: bortezomib-induced peripheral neuropathy; brain-derived neurotrophic factor; multiple myeloma.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Boronic Acids / administration & dosage
Boronic Acids / adverse effects*
Bortezomib
Brain-Derived Neurotrophic Factor / blood*
Female
Humans
Male
Middle Aged
Multiple Myeloma / blood*
Multiple Myeloma / drug therapy
Multiple Myeloma / genetics
Multiple Myeloma / metabolism
Peripheral Nervous System Diseases / blood*
Peripheral Nervous System Diseases / chemically induced*
Pyrazines / administration & dosage
Pyrazines / adverse effects*

Substances

Boronic Acids
Brain-Derived Neurotrophic Factor
Pyrazines
Bortezomib